Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Energy loss of argon in a laser-generated carbon plasma.
Frank A, Blazević A, Grande PL, Harres K, Hessling T, Hoffmann DH, Knobloch-Maas R, Kuznetsov PG, Nürnberg F, Pelka A, Schaumann G, Schiwietz G, Schökel A, Schollmeier M, Schumacher D, Schütrumpf J, Vatulin VV, Vinokurov OA, Roth M. Frank A, et al. Among authors: hessling t. Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Feb;81(2 Pt 2):026401. doi: 10.1103/PhysRevE.81.026401. Epub 2010 Feb 4. Phys Rev E Stat Nonlin Soft Matter Phys. 2010. PMID: 20365659
Time- and spectrally resolved measurements of laser-driven hohlraum radiation.
Hessling T, Blažević A, Frank A, Kraus D, Roth M, Schaumann G, Schumacher D, Stöhlker T, Hoffmann DH. Hessling T, et al. Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Jul;84(1 Pt 2):016412. doi: 10.1103/PhysRevE.84.016412. Epub 2011 Jul 28. Phys Rev E Stat Nonlin Soft Matter Phys. 2011. PMID: 21867327
Energy loss and charge transfer of argon in a laser-generated carbon plasma.
Frank A, Blažević A, Bagnoud V, Basko MM, Börner M, Cayzac W, Kraus D, Hessling T, Hoffmann DH, Ortner A, Otten A, Pelka A, Pepler D, Schumacher D, Tauschwitz A, Roth M. Frank A, et al. Among authors: hessling t. Phys Rev Lett. 2013 Mar 15;110(11):115001. doi: 10.1103/PhysRevLett.110.115001. Epub 2013 Mar 12. Phys Rev Lett. 2013. PMID: 25166546
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.
Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Liu E, et al. Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24. Neurology. 2015. PMID: 26208959 Free PMC article. Clinical Trial.